Zestoretic

   
Google
 
Web NewDrugInformation.com

Zestoretic


Drug - Zestoretic
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Lisinopril
Multiple ingredients are in alphabetical order.

Strength - 12.5MG;10MG
The potency of the active ingredient(s), Hydrochlorothiazide; Lisinopril. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Zestoretic. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019888
The FDA assigned number to Zestoretic. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Zestoretic. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 18, 1993
The date Zestoretic was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Zestoretic. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Zestoretic is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Uk Ltd
The full name of the firm holding legal responsibility for the new application of Zestoretic.

Zestoretic